Practices
Industries

OFAC Has Restricted Payments of Mandatory Contributions to the Budget of the Russian Federation for American Companies and Individuals

05 April 2023

On 27.03.2023 the Subcommission of the Government Commission for the Control of Foreign Investments published an Extract from the minutes of its meeting dated 02.03.2023. This document provides for a new requirement which has to be fulfilled in order to obtain Subcomission’s permission with regard to sale of shares of Russian companies. Foreigners from unfriendly states are now obliged to transfer funds to state budget in the amount of 5%-10% of the target’s valuation. 

Ministry of Finance Published List of Appraisers Recommended for Valuation of Assets to Obtain Permits from the Government Commission

03 March 2023

On 22 February 2023 the Ministry of Finance published on its official website a list of appraisers that the Ministry recommends to involve in the valuation of assets to obtain permits from the Government Commission within the framework of Presidential decrees No 79 of 28 February 2022 and No 81 of 01 March 2022. The list includes 42 appraisal organizations recommended for evaluation of business (stocks, shares, units) and real estate, and only real estate.

From 1 September 2023, Cargo Vehicles Will Be Able to Cross the Border of the Russian Federation Only After Preliminary Reservation

27 February 2023

On 17 February 2023, Federal Law No. 24-FZ of 17.02.2023 “On Amendments to Certain Legislative Acts of the Russian Federation” was published, amending the regulation of the movement of freight transport across the Russian border.

According to the new rules, starting from 1 September 2023, the crossing of the state border by cargo vehicles will be carried out through special crossing points after reserving the date and time.

Founder of a Major Russian Pharmaceutical Company Listed as SDN in the UK

09 February 2023

On 8 February 2023 Alexey Repik, the founder of R-Pharm – Russian pharmaceutical company, producing, among other things, drugs for COVID-19 (e.g. coronavir (favipiravir) and artlegia (olokizumab)) was listed in the UK Sanctions List.

Reasoning behind this decision is that he holds the position of the Chairman of the Board of R-Pharm, which receives financing from the Russian Direct Investment Fund – a Government of Russia-affiliated entity. Moreover, Alexey Repik is also designated as a person associated with Vladimir Putin, the Russian President.